The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma

PURPOSE: In patients with localised neuroblastoma without adverse genetic aberrations, observational treatment is justified. Therapy is required when organ or respiratory functions have become compromised. As the outcome is good, side effects of treatment should be prevented. The aim of this retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoot, Reineke A., Bleeker, Gitta, Caron, Huib N., van Eck, Berthe L., Heij, Hugo A., de Kraker, Jan, Tytgat, Godelieve A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779309/
https://www.ncbi.nlm.nih.gov/pubmed/23740371
http://dx.doi.org/10.1007/s00259-013-2455-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779309/
https://www.ncbi.nlm.nih.gov/pubmed/23740371
http://dx.doi.org/10.1007/s00259-013-2455-2

Ejemplares similares